These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38623386)

  • 21. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations.
    Bouzigues A; Russell LL; Peakman G; Bocchetta M; Greaves CV; Convery RS; Todd E; Rowe JB; Borroni B; Galimberti D; Tiraboschi P; Masellis M; Tartaglia MC; Finger E; van Swieten JC; Seelaar H; Jiskoot L; Sorbi S; Butler CR; Graff C; Gerhard A; Langheinrich T; Laforce R; Sanchez-Valle R; de Mendonça A; Moreno F; Synofzik M; Vandenberghe R; Ducharme S; Le Ber I; Levin J; Danek A; Otto M; Pasquier F; Santana I; Rohrer JD;
    J Neurol; 2022 Aug; 269(8):4322-4332. PubMed ID: 35348856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia.
    Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F;
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study.
    Premi E; Pengo M; Mattioli I; Cantoni V; Dukart J; Gasparotti R; Buratti E; Padovani A; Bocchetta M; Todd EG; Bouzigues A; Cash DM; Convery RS; Russell LL; Foster P; Thomas DL; van Swieten JC; Jiskoot LC; Seelaar H; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Tsvetanov KA; Vandenberghe R; Finger E; Tiraboschi P; de Mendonça A; Santana I; Butler CR; Ducharme S; Gerhard A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Rohrer JD; Borroni B;
    Neurobiol Dis; 2023 Apr; 179():106068. PubMed ID: 36898614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential early subcortical involvement in genetic FTD within the GENFI cohort.
    Bocchetta M; Todd EG; Peakman G; Cash DM; Convery RS; Russell LL; Thomas DL; Eugenio Iglesias J; van Swieten JC; Jiskoot LC; Seelaar H; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Rohrer JD;
    Neuroimage Clin; 2021; 30():102646. PubMed ID: 33895632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.
    O'Bryant SE; Lacritz LH; Hall J; Waring SC; Chan W; Khodr ZG; Massman PJ; Hobson V; Cullum CM
    Arch Neurol; 2010 Jun; 67(6):746-9. PubMed ID: 20558394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodromal frontotemporal dementia: clinical features and predictors of progression.
    Benussi A; Ashton NJ; Karikari TK; Alberici A; Saraceno C; Ghidoni R; Benussi L; Zetterberg H; Blennow K; Borroni B
    Alzheimers Res Ther; 2021 Nov; 13(1):188. PubMed ID: 34782010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translation, cross-cultural adaptation and applicability of the Brazilian version of the Frontotemporal Dementia Rating Scale (FTD-FRS).
    Lima-Silva TB; Bahia VS; Carvalho VA; Guimarães HC; Caramelli P; Balthazar M; Damasceno B; Bottino CMC; Brucki SMD; Mioshi E; Nitrini R; Yassuda MS
    Dement Neuropsychol; 2013; 7(4):387-396. PubMed ID: 29213863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Looking for Measures of Disease Severity in the Frontotemporal Dementia Continuum.
    Premi E; Gualeni V; Costa P; Cosseddu M; Gasparotti R; Padovani A; Borroni B
    J Alzheimers Dis; 2016 Apr; 52(4):1227-35. PubMed ID: 27104906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort.
    Gentry MT; Lapid MI; Syrjanen J; Calvert K; Hughes S; Brushaber D; Kremers W; Bove J; Brannelly P; Coppola G; Dheel C; Dickerson B; Dickinson S; Faber K; Fields J; Fong J; Foroud T; Forsberg L; Gavrilova R; Gearhart D; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford N; Grossman M; Haley D; Heuer H; Hsiung GY; Huey E; Irwin D; Jones D; Jones L; Kantarci K; Karydas A; Knopman D; Kornak J; Kramer J; Kukull W; Lucente D; Lungu C; Mackenzie I; Manoochehri M; McGinnis S; Miller B; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin K; Rascovsky K; Sengdy P; Shaw L; Tatton N; Taylor J; Toga A; Trojanowski J; Weintraub S; Wong B; Wszolek Z; Boeve BF; Boxer A; Rosen H;
    Alzheimers Dement; 2020 Aug; 16(8):1115-1124. PubMed ID: 32656921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort.
    Bocchetta M; Todd EG; Bouzigues A; Cash DM; Nicholas JM; Convery RS; Russell LL; Thomas DL; Malone IB; Iglesias JE; van Swieten JC; Jiskoot LC; Seelaar H; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Rohrer JD;
    Brain Commun; 2023; 5(2):fcad061. PubMed ID: 36970046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia.
    Mioshi E; Flanagan E; Knopman D
    Int J Geriatr Psychiatry; 2017 Sep; 32(9):977-982. PubMed ID: 27464599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study.
    Borroni B; Agosti C; Premi E; Cerini C; Cosseddu M; Paghera B; Bellelli G; Padovani A
    Eur J Neurol; 2010 May; 17(5):703-7. PubMed ID: 20050899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients.
    Maiovis P; Ioannidis P; Gerasimou G; Gotzamani-Psarrakou A; Karacostas D
    J Neuropsychiatry Clin Neurosci; 2017; 29(1):26-30. PubMed ID: 27417072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining the presymptomatic phase of frontotemporal dementia.
    Russell LL; Rohrer JD
    Curr Opin Neurol; 2023 Aug; 36(4):276-282. PubMed ID: 37340685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort.
    Samra K; MacDougall AM; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; van Swieten JC; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tiraboschi P; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD; Russell LL;
    J Neurol Sci; 2023 Aug; 451():120711. PubMed ID: 37348248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise?
    Altomare D; Rivolta J; Libri I; Mattioli I; Cantoni V; Padovani A; Borroni B
    J Alzheimers Dis; 2024; 98(1):133-144. PubMed ID: 38363612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptation and validation of a Spanish-language version of the Frontotemporal Dementia Rating Scale (FTD-FRS).
    Turró-Garriga O; Hermoso Contreras C; Olives Cladera J; Mioshi E; Pelegrín Valero C; Olivera Pueyo J; Garre-Olmo J; Sánchez-Valle R
    Neurologia; 2017 Jun; 32(5):290-299. PubMed ID: 26877196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
    Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
    Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.